Expression of LTC4 synthase during the development of eosinophils in vitro from cord blood progenitors

Blood

Volumn 88, Issue 11, 1996, Pages 4338-4347

  Boyce, Joshua A ^a   Lam, Bing K ^b   Penrose, John F ^b   Friend, Daniel S ^b   Parsons, Stephanie ^b   Owen, William F ^b   Austen, K Frank ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; BETA ACTIN; CALCIMYCIN; CD34 ANTIGEN; LEUKOTRIENE C4; MESSENGER RNA; PEPTIDOLEUKOTRIENE; PHOSPHOLIPASE A2; SYNTHETASE; 5-LIPOXYGENASE-ACTIVATING PROTEIN; ARACHIDONATE 5 LIPOXYGENASE ACTIVATING PROTEIN; CALCIUM; CARRIER PROTEIN; COLLAGEN; GLUTATHIONE TRANSFERASE; INTERLEUKIN 3; INTERLEUKIN 5; IONOPHORE; LAMININ; LEUKOTRIENE; LEUKOTRIENE C4 SYNTHASE; LEUKOTRIENE-C4 SYNTHASE; LIPOXYGENASE; MATRIGEL; MEMBRANE PROTEIN; PHOSPHOLIPASE A; PROTEOGLYCAN; RECOMBINANT PROTEIN;

ARTICLE; CELL MATURATION; CONTROLLED STUDY; EOSINOPHIL; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MONONUCLEAR CELL; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; UMBILICAL CORD BLOOD; BIOSYNTHESIS; CELL CULTURE; CYTOLOGY; DRUG COMBINATION; DRUG EFFECT; ENZYME INDUCTION; ENZYMOLOGY; FETUS BLOOD; GENETICS; METABOLISM; NEWBORN; PHENOTYPE; PHYSIOLOGY;

CALCIMYCIN; CALCIUM; CARRIER PROTEINS; CELLS, CULTURED; COLLAGEN; DRUG COMBINATIONS; ENZYME INDUCTION; EOSINOPHILS; FETAL BLOOD; GLUTATHIONE TRANSFERASE; HEMATOPOIETIC STEM CELLS; HUMANS; INFANT, NEWBORN; INTERLEUKIN-3; INTERLEUKIN-5; IONOPHORES; LAMININ; LEUKOTRIENES; LIPOXYGENASE; MEMBRANE PROTEINS; PHENOTYPE; PHOSPHOLIPASES A; PROTEOGLYCANS; RECOMBINANT PROTEINS; RNA, MESSENGER;

EID: 0029662066     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.11.4338.4338     Document Type: Article

References (43)

1. 4 in normal and asthmatic subjects. Am Rev Respir Dis 135:333, 1987
2. 4 on the airways in asthma. N Engl J Med 308:436, 1983
3. 4, increase the release of mucus from human airways in vitro. Am Rev Respir Dis 126:449, 1982
4. 4) in human skin. J Invest Derm 80:115, 1983
5. 4 from the urine of patients with airway obstruction. Am Rev Respir Dis 146:104, 1992
6. 4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects. Am Rev Respir Dis 143:1025, 1991
7. Israel E, Rubin P, Kemp JP, Grossman J, Pierson W, Sielgel SC, Tinkelman D, Murray JJ, Busse W, Segal AT, Fish J, Kaiser HB, Ledford D, Wenzel S, Rosenthal R, Conn J, Lanni C, Pearlman H, Karahalios P, Drazen JM: The effect of inhibition of 5-lipoxygenase by zileuton in mild-to-moderate asthma. Ann Intern Med 119:1059, 1993
8. Israel E, Juniper EF, Callaghan JT, Mathur PN, Morris MM, Dowell AR, Enas GG, Hargreave FE, Drazen JM: Effect of a leukotriene antagonist, LY171883, on cold air-induced bronchoconstriction in asthmatics. Am Rev Respir Dis 140:1348, 1989
9. 4. Proc Natl Acad Sci USA 80:7626, 1983
10. 4 by human eosinophils. J Immunol 138:532, 1987
11. MacGlashan DW Jr, Peters SP, Warner J, Lichtenstein LM: Characteristics of human basophil sulfidopeptide leukotriene release: Releasability defined as the ability of the basophil to respond to dimeric cross-links. J Immunol 136:2231, 1986
12. MacGlashan DW Jr, Schleimer RP, Peters SP, Schulman ES, Adams GK III, Newball NH, Lichtenstein LM: Generation of leukotrienes by purified human lung mast cells. J Clin Invest 70:747, 1985
13. 2+-dependent translocation domain with homology to PKC and GAP. Cell 65:1043, 1991
14. Dixon RAF, Diehl RE, Opas E, Rands E, Vickers PJ, Evans JF, Gillard JW, Miller DK: Requirement of a 5-lipoxygenase-activating protein for leukotriene biosynthesis. Nature 343:282, 1990
15. 4 synthase: A homodimeric glutathione S-transferase composed of 18-kDa subunits. Proc Natl Acad Sci USA 90:2015, 1993
16. 4 synthase. Proc Natl Acad Sci USA 91:9745, 1994
17. 4. Proc Natl Acad Sci USA 91:7663, 1994
18. 4 by human eosinophils. J Biol Chem 264:12885, 1989
19. 4 and γ-glutamyl amino acids. Proc Natl Acad Sci USA 79:1088, 1982
20. 4 by a dipeptidase released from the specific granules of human polymorphonuclear leukocytes. Immunology 48:27, 1983
21. 4 hydrolase from rat neutrophils. Biochim Biophys Acta 840:43, 1985
22. 2 from human monocytes stimulated with aggregated IgG, IgA, and IgE. J Immunol 136:4188, 1986
23. 4 on ionophore A23187 challenge. J Allergy Clin Immunol 74:310, 1984
24. Rothenberg ME, Petersen J, Stevens RL, Silberstein DS, McKenzie DT, Austen KF, Owen WF: IL-5-dependent conversion of normodense eosinophils to the hypodense phenotype uses 3T3 fibroblasts for enhanced viability, accelerated hypodensity, and sustained antibody-dependent cytotoxicity. J Immunol 143:2311, 1989
25. 4 in response to FMLP. J Clin Invest 87:1958, 1991
26. Rothenberg ME, Owen WF, DS Silberstein, Woods J, Soberman RJ, KF Austen, Stevens RL: Human eosinophils have prolonged survival, enhanced function, and become hypodense when exposed to human interleukin 3. J Clin Invest 81:1986, 1988
27. Walsh GM, Hartnell A, Moqbel R, Cromwell O, Nagy L, Bradley B, Furitsu T, Ishizaka T, Kay AB: Receptor expression and functional status of human eosinophils derived from umbilical cord blood mononuclear cells. Blood 76:105, 1990
28. 4 synthase and preparation of a polyclonal antibody. Am J Respir Crit Care Med 152:283, 1995
29. Boyce JA, Friend D, Matsumoto R, Austen KF, Owen WF: Differentiation in vitro of hybrid eosinophil/basophil granulocytes: autocrine function of an eosinophil developmental intermediate. J Exp Med 182:49, 1995
30. Boyce JA, Friend D, Gurish MF, Austen KF, Owen WF: Constitutive production of GM-CSF by mononuclear eosinophils developed in vitro from hybrid eosinophil/basophil granulocytes. Proc Natl Acad Sci USA 93:2436, 1996
31. Miltenyi S, Guth S, Radbruch A, Pfluger E, Theil A: Isolation of CD34+ hematopoietic progenitor cells by high-gradient magnetic cell sorting (MACS), in Wunder E (ed): Hematopoietic Stem Cells: The Mulhouse Manual. Dayton, OH, AlphaMed, 1994, p 201
32. Hansel TT, De Vries IJ, Iff T, Rihs S, Wandzilak M, Betz S, Blaser K, Walker C: An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils. J Immunol Methods 145:105, 1991
33. 4 diastereoisomers and the subclass-specific S-diastereoisomeric sulfoxides. J Biol Chem 258:15004, 1983
34. Reid GK, Kargman S, Vickers PJ, Mancini JA, Leveille C, Ethier D, Miller DK, Gillard JW, Dixon RAF, Evans JF: Correlation between expression of 5-lipoxygenase-activating protein, 5-lipoxygenase, and cellular leukotriene synthesis. J Biol Chem 265:19818, 1990
35. Maytin EV, Levin EN, Anderson RR: A laser densitometer for selective spot analysis on dot blots and two-dimensional gel autoradiograms. Anal Biochem 194:284, 1991
36. 4 synthase pathway in mouse mast cells. J Biol Chem 270:22653, 1995
37. Gruart V, Truong M-J, Plumas J, Zandecki M, Kusnierz J-P, Vinatier D, Capron A, Capron M: Decreased expression of eosinophil peroxidase and major basic protein messenger RNAs during eosinophil maturation. Blood 79:2592, 1992
38. Abramovitz M, Wong E, Cox M, Richardson CD, Li C, Vickers P: 5-Lipoxygenase-activating protein stimulates the utilization of arachidonic acid by 5-lipoxygenase. Eur J Biochem 215:105, 1993
39. Coffey MJ, Wilcoxen SE, Peters-Golden M: Increases in 5-lipoxygenase activating protein expression account for enhanced capacity for 5-lipoxygenase metabolism that accompanies differentiation of peripheral blood monocytes into alveolar macrophages. Am J Respir Cell Mol Biol 11:153, 1994
40. Saito H, Hatake K, Dvorak AM, Leiferman KM, Donnenberg AD, Arai N, Ishizaka K, Ishizaka T: Selective differentiation and proliferation of hematopoietic cells induced by recombinant interleukins. Proc Natl Acad Sci USA 85:2288, 1988
41. Stankova J, Rola-Plesczynski M, Dubois CM: Granulocyte-macrophage colony-stimulating factor increases 5-lipoxygenase gene transcription and protein expression in human neutrophils. Blood 85:3719, 1995
42. Palmantier R, Surette ME, Sanchez A, Braquet P, Borgeat P: Priming for the synthesis of 5-lipoxygenase products in human blood ex vivo by human granulocyte-macrophage colony-stimulating factor and tumor-necrosis factor alpha. Lab Invest 70:696, 1994
43. Parker CW, Falkenhein SF, Huber MM: Sequential conversion of the glutathionyl side chain of slow reacting substance (SRS) to cysteinyl-glycine and cysteine in rat basophilic leukemia cells stimulated with A-23187. Prostaglandins 20:863, 1980